Quest Diagnostics Incorporated (DGX) Q4 2025 (USD): EPS 2.42 (exp. 2.36), Revenue 2.81bln (exp. 2.75bln), Next FY EPS 10.50-10.70 (exp. 10.42), Next FY Rev. 11.7-11.82bln (exp. 11.38bln)

Quest Diagnostics' Q4 results beat expectations on both EPS and revenue, indicating strong operational performance.

Newsquawk StaffPublished On the live feed at 9 more headlines followed before this page went public
Newsquawk headlinesUTC

"US ambassador to Israel Huckabed, ahead of departure with [Israeli PM] Netanyahu to US, says, ‘No significant gaps between Israel, US on demands from Iran", via Amichai Stein on X

Stellantis (STLAM IM) cut to Baa3 (prev. Baa3) at Moody's, outlook Stable

Quest Diagnostics Incorporated (DGX) Q4 2025 (USD): EPS 2.42 (exp. 2.36), Revenue 2.81bln (exp. 2.75bln), Next FY EPS 10.50-10.70 (exp. 10.42), Next FY Rev. 11.7-11.82bln (exp. 11.38bln)

Ferrari (RACE IM) Q4 (EUR) EPS 2.14 (exp. 2.05), Revenue 1.80bln (exp. 1.7bln); guides initial FY26 EPS "more than" 9.45 (exp. 9.55), Revenue approx. 7.50bln (exp. 7.53bln)

Hasbro Inc. (HAS) Q4 2025 (USD): Revenue 1.45bln (exp. 1.26bln), EPS 1.51 (exp. 0.96); buyback shares of USD 1bln

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

The upward guidance for next fiscal year suggests management is optimistic about growth, which may lead to a positive reaction in the stock and potentially enhance sentiment towards the healthcare sector as a whole.

Related headlines

The whole workspace, free to try.

Try it free